Takami Tomiyama

4.8k total citations
83 papers, 3.9k citations indexed

About

Takami Tomiyama is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Takami Tomiyama has authored 83 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Physiology, 34 papers in Molecular Biology and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Takami Tomiyama's work include Alzheimer's disease research and treatments (70 papers), Cholinesterase and Neurodegenerative Diseases (13 papers) and Neuroscience and Neuropharmacology Research (12 papers). Takami Tomiyama is often cited by papers focused on Alzheimer's disease research and treatments (70 papers), Cholinesterase and Neurodegenerative Diseases (13 papers) and Neuroscience and Neuropharmacology Research (12 papers). Takami Tomiyama collaborates with scholars based in Japan, United States and Netherlands. Takami Tomiyama's co-authors include Hiroshi Mori, Tomohiro Umeda, Noriaki Endo, Satoshi Asano, William L. Klein, Mary P. Lambert, Hiroyuki Shimada, Hiroshi Takuma, Rie Teraoka and Hideshi Kaneko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Takami Tomiyama

82 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takami Tomiyama Japan 32 2.9k 1.5k 787 712 610 83 3.9k
Elizabeth A. Eckman United States 24 2.6k 0.9× 1.6k 1.1× 577 0.7× 644 0.9× 611 1.0× 40 3.9k
Thierry Bussière United States 21 3.0k 1.1× 1.6k 1.0× 922 1.2× 720 1.0× 813 1.3× 29 4.1k
Steffen Roßner Germany 35 2.6k 0.9× 2.0k 1.3× 1.4k 1.7× 840 1.2× 814 1.3× 114 4.9k
Suzanne Y. Guénette United States 20 3.6k 1.2× 2.2k 1.5× 908 1.2× 830 1.2× 527 0.9× 30 4.7k
Reisuke H. Takahashi Japan 21 2.5k 0.9× 1.4k 0.9× 1.1k 1.4× 674 0.9× 533 0.9× 33 3.6k
Dieder Moechars Belgium 38 2.7k 0.9× 1.8k 1.2× 1.3k 1.7× 800 1.1× 395 0.6× 67 4.5k
Alfredo Lorenzo Argentina 22 3.1k 1.1× 2.1k 1.4× 874 1.1× 776 1.1× 582 1.0× 35 4.6k
Paul E. Fraser Canada 23 2.8k 1.0× 1.7k 1.1× 799 1.0× 707 1.0× 728 1.2× 34 4.0k
Eduardo M. Castaño Argentina 33 3.8k 1.3× 2.5k 1.7× 585 0.7× 684 1.0× 672 1.1× 73 4.9k
Amaya García-Muñoz Ireland 12 2.5k 0.9× 1.6k 1.1× 933 1.2× 637 0.9× 573 0.9× 15 3.8k

Countries citing papers authored by Takami Tomiyama

Since Specialization
Citations

This map shows the geographic impact of Takami Tomiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takami Tomiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takami Tomiyama more than expected).

Fields of papers citing papers by Takami Tomiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takami Tomiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takami Tomiyama. The network helps show where Takami Tomiyama may publish in the future.

Co-authorship network of co-authors of Takami Tomiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Takami Tomiyama. A scholar is included among the top collaborators of Takami Tomiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takami Tomiyama. Takami Tomiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seino, Satoshi, Tomohiro Umeda, Takami Tomiyama, et al.. (2024). Investigating the efficacy of nasal administration for delivering magnetic nanoparticles into the brain for magnetic particle imaging. Journal of Controlled Release. 367. 515–521. 10 indexed citations
2.
Umeda, Tomohiro, et al.. (2024). New Value of Acorus tatarinowii/gramineus Leaves as a Dietary Source for Dementia Prevention. Nutrients. 16(11). 1589–1589. 3 indexed citations
3.
Chang, Chia-Jung, Zacharie Taoufiq, Hiroshi Yamada, et al.. (2024). The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer’s disease model mice. Brain Research. 1838. 148987–148987. 2 indexed citations
4.
5.
Nomura, Sachiko, et al.. (2022). Peripheral Aβ acts as a negative modulator of insulin secretion. Proceedings of the National Academy of Sciences. 119(12). e2117723119–e2117723119. 9 indexed citations
6.
Umeda, Tomohiro, et al.. (2022). C9orf72 Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice. Biomedicines. 10(5). 1080–1080. 3 indexed citations
7.
Umeda, Tomohiro, et al.. (2021). Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers. International Journal of Molecular Sciences. 22(16). 8453–8453. 14 indexed citations
8.
Shimada, Hiroyuki, Jun Takeuchi, Akitoshi Takeda, et al.. (2020). Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation. International Journal of Molecular Sciences. 21(12). 4443–4443. 9 indexed citations
9.
Kadoyama, Keiichi, Kenji Matsuura, Masaoki Takano, et al.. (2020). Proteomic analysis involved with synaptic plasticity improvement by GABAA receptor blockade in hippocampus of a mouse model of Alzheimer’s disease. Neuroscience Research. 165. 61–68. 7 indexed citations
10.
Kasai, Takashi, Masaki Kondo, Ryotaro Ishii, et al.. (2017). Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer’s disease. PLoS ONE. 12(4). e0174630–e0174630. 6 indexed citations
11.
Umeda, Tomohiro, Kenjiro Ono, M. Yamashita, et al.. (2016). Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers. Brain. 139(5). 1568–1586. 100 indexed citations
12.
Tomiyama, Takami. (2010). [Involvement of beta-amyloid in the etiology of Alzheimer's disease].. PubMed. 62(7). 691–9. 13 indexed citations
13.
Ito, Kazuhiro, Kenichi Ishibashi, Takami Tomiyama, et al.. (2009). Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form. Current Alzheimer Research. 6(2). 132–136. 3 indexed citations
14.
Matsuyama, Shogo, Rie Teraoka, Hiroshi Mori, & Takami Tomiyama. (2007). Inverse correlation between amyloid precursor protein and synaptic plasticity in transgenic mice. Neuroreport. 18(10). 1083–1087. 21 indexed citations
15.
Sennvik, Kristina, Karin Boekhoorn, Reena Lasrado, et al.. (2007). Tau‐4R suppresses proliferation and promotes neuronal differentiation in the hippocampus of tau knockin/ knockout mice. The FASEB Journal. 21(9). 2149–2161. 59 indexed citations
16.
Ishibashi, Kenichi, Takami Tomiyama, Kazuchika Nishitsuji, Mitsuhiro Hara, & Hiroshi Mori. (2006). Absence of synaptophysin near cortical neurons containing oligomer Aβ in Alzheimer's disease brain. Journal of Neuroscience Research. 84(3). 632–636. 33 indexed citations
17.
Takuma, Hiroshi, Takami Tomiyama, Keisuke Kuida, & Hiroshi Mori. (2004). Amyloid Beta Peptide-Induced Cerebral Neuronal Loss Is Mediated By Caspase-3 In Vivo. Journal of Neuropathology & Experimental Neurology. 63(3). 255–261. 53 indexed citations
18.
Ishii, Kazuhiro, Carol F. Lippa, Takami Tomiyama, et al.. (2001). Distinguishable effects of Presenilin-1 and APP717 mutations on amyloid plaque deposition. Neurobiology of Aging. 22(3). 367–376. 18 indexed citations
19.
Sahara, Naruhiko, Takami Tomiyama, & Hiroshi Mori. (2000). Missense point mutations of tau to segregate with FTDP-17 exhibit site-specific effects on microtubule structure in COS cells: A novel action of R406W mutation. Journal of Neuroscience Research. 60(3). 380–387. 31 indexed citations
20.
Tomiyama, Takami, Douglas F. Lake, Yasuhiko Masuho, & Evan M. Hersh. (1991). Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum. Biochemical and Biophysical Research Communications. 177(1). 279–285. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth A. Eckman Breakdown of academic impact, for papers by Thierry Bussière Breakdown of academic impact, for papers by Steffen Roßner Breakdown of academic impact, for papers by Suzanne Y. Guénette Breakdown of academic impact, for papers by Reisuke H. Takahashi Breakdown of academic impact, for papers by Dieder Moechars Breakdown of academic impact, for papers by Alfredo Lorenzo Breakdown of academic impact, for papers by Paul E. Fraser Breakdown of academic impact, for papers by Eduardo M. Castaño Breakdown of academic impact, for papers by Amaya García-Muñoz
Rankless by CCL
2026